PHARMACOKINETIC (PK) STUDIES FOR RXFP1-AGONISTS

AI Summary

The National Institutes of Health is soliciting proposals for pharmacokinetic studies related to RXFP1-agonists. This opportunity is a competitive solicitation for commercial services, and the contract will be awarded based on the best value to the Government. Proposals are due by August 24, 2026.

Contract details

Solicitation No.: 75N98026Q00976
Notice Type: Solicitation
Posted Date: August 7, 2026
Response Deadline: August 24, 2026
NAICS Code: 541380 AI guide
PSC / Class Code: R499
Issuing Office: NATIONAL INSTITUTES OF HEALTH OLAO
Sub-Agency: NATIONAL INSTITUTES OF HEALTH
Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES
Primary Contact: JOHNSTON, JADDUA C
City: BETHESDA
State: MD
ZIP Code: 20892
AI Product/Service: service

Description

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q00976. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026

(iv) The associated NAICS code is 541380 Testing Laboratories and Services, and the small business size standard is $19.0 million.

This requirement is unrestricted.

Key dates

August 7, 2026Posted Date
August 24, 2026Proposals / Responses Due

AI search tags

pharmacokinetic studies testing laboratories clinical research biomedical services

Frequently asked questions

PHARMACOKINETIC (PK) STUDIES FOR RXFP1-AGONISTS is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.